(LIN) Linde Ordinary Shares - Ratings and Ratios

Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: IE000S9YS762

Oxygen, Nitrogen, Argon, Hydrogen, Helium, Carbon Dioxide

LIN EPS (Earnings per Share)

EPS (Earnings per Share) of LIN over the last years for every Quarter: "2020-09-30": 2.15, "2020-12-31": 2.3, "2021-03-31": 2.49, "2021-06-30": 2.7, "2021-09-30": 2.73, "2021-12-31": 2.77, "2022-03-31": 2.93, "2022-06-30": 3.1, "2022-09-30": 3.1, "2022-12-31": 3.16, "2023-03-31": 3.42, "2023-06-30": 3.57, "2023-09-30": 3.63, "2023-12-31": 3.59, "2024-03-31": 3.75, "2024-06-30": 3.85, "2024-09-30": 3.22, "2024-12-31": 3.6, "2025-03-31": 3.51, "2025-06-30": 4.09,

LIN Revenue

Revenue of LIN over the last years for every Quarter: 2020-09-30: 6855, 2020-12-31: 7272, 2021-03-31: 7243, 2021-06-30: 7584, 2021-09-30: 7668, 2021-12-31: 8298, 2022-03-31: 8211, 2022-06-30: 8457, 2022-09-30: 8797, 2022-12-31: 7899, 2023-03-31: 8193, 2023-06-30: 8204, 2023-09-30: 8155, 2023-12-31: 8302, 2024-03-31: 8100, 2024-06-30: 8267, 2024-09-30: 8356, 2024-12-31: 8282, 2025-03-31: 8112, 2025-06-30: 8495,

Description: LIN Linde Ordinary Shares

Linde plc is a leading industrial gas company operating globally, with a presence in key regions including the United States, China, Germany, the United Kingdom, Australia, Mexico, and Brazil. The company provides a broad portfolio of products, including atmospheric gases (oxygen, nitrogen, argon, and rare gases) and process gases (hydrogen, helium, carbon dioxide, etc.), catering to diverse industries such as healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics.

The companys business model extends beyond gas production, as it also designs and constructs turnkey process plants for both third-party customers and its own gas businesses. These plants encompass various technologies, including air separation, hydrogen, synthesis, olefin, and natural gas plants, showcasing Lindes capabilities in engineering and project execution. With a history dating back to 1879, Linde has established itself as a veteran player in the industrial gases sector.

From a financial perspective, Linde plc exhibits strong performance indicators. The companys Return on Equity (RoE) stands at 17.23%, indicating efficient use of shareholder capital. Additionally, the dividend yield, although not explicitly mentioned, is an important metric for income-focused investors. Lindes global presence and diversified customer base across various industries contribute to its stability and growth prospects. Key Performance Indicators (KPIs) such as revenue growth, EBITDA margins, and debt-to-equity ratio are crucial in assessing the companys financial health and operational efficiency. For instance, a high EBITDA margin would suggest strong operational profitability, while a manageable debt-to-equity ratio would indicate a healthy capital structure.

To further evaluate Lindes investment potential, its essential to consider industry trends, competitive positioning, and growth drivers. The industrial gases market is expected to grow due to increasing demand from emerging economies and the need for cleaner energy solutions. Lindes ability to innovate and expand its product offerings, as well as its capacity to execute large-scale projects, will be critical in maintaining its market share and driving future growth. Investors should monitor KPIs such as the companys market share, new project wins, and R&D investments to gauge its competitiveness and growth prospects.

LIN Stock Overview

Market Cap in USD 226,033m
Sub-Industry Industrial Gases
IPO / Inception 2002-01-11

LIN Stock Ratings

Growth Rating 70.1%
Fundamental 67.6%
Dividend Rating 61.7%
Return 12m vs S&P 500 -15.3%
Analyst Rating 4.0 of 5

LIN Dividends

Dividend Yield 12m 1.27%
Yield on Cost 5y 2.56%
Annual Growth 5y 7.62%
Payout Consistency 100.0%
Payout Ratio 40.9%

LIN Growth Ratios

Growth Correlation 3m 71.2%
Growth Correlation 12m 36.5%
Growth Correlation 5y 94.7%
CAGR 5y 20.52%
CAGR/Max DD 3y 1.38
CAGR/Mean DD 3y 5.80
Sharpe Ratio 12m -0.31
Alpha 0.09
Beta 0.782
Volatility 17.81%
Current Volume 1470.5k
Average Volume 20d 1618k
Stop Loss 457.3 (-3%)
Signal -1.50

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (6.71b TTM) > 0 and > 6% of Revenue (6% = 1.99b TTM)
FCFTA 0.06 (>2.0%) and ΔFCFTA -0.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -3.27% (prev -2.01%; Δ -1.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 9.91b > Net Income 6.71b (YES >=105%, WARN >=100%)
Net Debt (21.13b) to EBITDA (12.88b) ratio: 1.64 <= 3.0 (WARN <= 3.5)
Current Ratio 0.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (473.6m) change vs 12m ago -1.99% (target <= -2.0% for YES)
Gross Margin 40.08% (prev 35.94%; Δ 4.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 39.98% (prev 40.92%; Δ -0.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 21.43 (EBITDA TTM 12.88b / Interest Expense TTM 427.0m) >= 6 (WARN >= 3)

Altman Z'' 1.40

(A) -0.01 = (Total Current Assets 13.63b - Total Current Liabilities 14.71b) / Total Assets 86.08b
(B) 0.17 = Retained Earnings (Balance) 14.60b / Total Assets 86.08b
(C) 0.11 = EBIT TTM 9.15b / Avg Total Assets 83.15b
(D) 0.18 = Book Value of Equity 8.35b / Total Liabilities 46.09b
Total Rating: 1.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.57

1. Piotroski 6.50pt = 1.50
2. FCF Yield 2.05% = 1.03
3. FCF Margin 15.25% = 3.81
4. Debt/Equity 0.67 = 2.28
5. Debt/Ebitda 2.01 = -0.03
6. ROIC - WACC (= 3.40)% = 4.24
7. RoE 17.46% = 1.46
8. Rev. Trend 1.83% = 0.14
9. EPS Trend 62.76% = 3.14

What is the price of LIN shares?

As of September 18, 2025, the stock is trading at USD 471.47 with a total of 1,470,549 shares traded.
Over the past week, the price has changed by -0.42%, over one month by -1.16%, over three months by +1.37% and over the past year by +0.55%.

Is Linde Ordinary Shares a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Linde Ordinary Shares (NASDAQ:LIN) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 67.57 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LIN is around 496.48 USD . This means that LIN is currently overvalued and has a potential downside of 5.3%.

Is LIN a buy, sell or hold?

Linde Ordinary Shares has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy LIN.
  • Strong Buy: 12
  • Buy: 6
  • Hold: 9
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the LIN price?

Issuer Target Up/Down from current
Wallstreet Target Price 511 8.4%
Analysts Target Price 511 8.4%
ValueRay Target Price 550.9 16.9%

Last update: 2025-09-15 04:39

LIN Fundamental Data Overview

Market Cap USD = 226.03b (226.03b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 4.79b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.2358
P/E Forward = 26.738
P/S = 6.799
P/B = 5.8687
P/EG = 2.2442
Beta = 0.952
Revenue TTM = 33.24b USD
EBIT TTM = 9.15b USD
EBITDA TTM = 12.88b USD
Long Term Debt = 19.70b USD (from longTermDebt, last quarter)
Short Term Debt = 6.22b USD (from shortTermDebt, last quarter)
Debt = 25.92b USD (Calculated: Short Term 6.22b + Long Term 19.70b)
Net Debt = 21.13b USD (from netDebt column, last quarter)
Enterprise Value = 247.17b USD (226.03b + Debt 25.92b - CCE 4.79b)
Interest Coverage Ratio = 21.43 (Ebit TTM 9.15b / Interest Expense TTM 427.0m)
FCF Yield = 2.05% (FCF TTM 5.07b / Enterprise Value 247.17b)
FCF Margin = 15.25% (FCF TTM 5.07b / Revenue TTM 33.24b)
Net Margin = 20.20% (Net Income TTM 6.71b / Revenue TTM 33.24b)
Gross Margin = 40.08% ((Revenue TTM 33.24b - Cost of Revenue TTM 19.92b) / Revenue TTM)
Tobins Q-Ratio = 29.62 (Enterprise Value 247.17b / Book Value Of Equity 8.35b)
Interest Expense / Debt = 0.26% (Interest Expense 67.0m / Debt 25.92b)
Taxrate = 22.91% (2.00b / 8.74b)
NOPAT = 7.05b (EBIT 9.15b * (1 - 22.91%))
Current Ratio = 0.93 (Total Current Assets 13.63b / Total Current Liabilities 14.71b)
Debt / Equity = 0.67 (Debt 25.92b / last Quarter total Stockholder Equity 38.52b)
Debt / EBITDA = 2.01 (Net Debt 21.13b / EBITDA 12.88b)
Debt / FCF = 5.11 (Debt 25.92b / FCF TTM 5.07b)
Total Stockholder Equity = 38.45b (last 4 quarters mean)
RoA = 7.80% (Net Income 6.71b, Total Assets 86.08b )
RoE = 17.46% (Net Income TTM 6.71b / Total Stockholder Equity 38.45b)
RoCE = 15.74% (Ebit 9.15b / (Equity 38.45b + L.T.Debt 19.70b))
RoIC = 11.40% (NOPAT 7.05b / Invested Capital 61.88b)
WACC = 8.00% (E(226.03b)/V(251.95b) * Re(8.90%)) + (D(25.92b)/V(251.95b) * Rd(0.26%) * (1-Tc(0.23)))
Shares Correlation 3-Years: -100.00 | Cagr: -0.51%
Discount Rate = 8.90% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 73.94% ; FCFE base≈4.98b ; Y1≈4.62b ; Y5≈4.22b
Fair Price DCF = 138.6 (DCF Value 64.99b / Shares Outstanding 468.9m; 5y FCF grow -9.18% → 3.0% )
EPS Correlation: 62.76 | EPS CAGR: 10.60% | SUE: 0.44 | # QB: 0
Revenue Correlation: 1.83 | Revenue CAGR: -1.26% | SUE: N/A | # QB: None

Additional Sources for LIN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle